None | 01 Oct 2010 | Africa Fighting Malaria
As the United States has demonstrated over the past century, drug
quality is partly dictated by the drug regulatory environment. Without
at least basic quality control, cheats can flourish and quality can be
None | 30 Jun 2010 | Africa Fighting Malaria
Drug resistance is seriously undermining efforts to cure disease in developing countries, a new report by the Center for Global Development (CGD) warns. The report argues that although eventual resistance is inevitable, it has been accelerated unnecessarily by careless practices in drug supply and use.
None | 28 Jun 2010 | Africa Fighting Malaria
News out on Friday from Cambodia reports that efforts to control emerging ACT drug resistance is paying off. Dr. Duong Socheat, head of Cambodia's National Center for Malaria Control, reports that the results from their work have been very encouraging.
Roger Bate | 15 Jun 2010 | American.com
A new study finds public- and private-sector efforts having a positive effect on poor quality medicines in two West African cities. Substandard and counterfeit drugs can be lethal to patients and accelerate drug resistance across at-risk populations.
Roger Bate | 17 May 2010 | Wall Street Journal
The Food and Drug Administration of the Indian State of Uttar Pradesh recently conducted a series of raids throughout its region to uncover counterfeit drugs. The raids yielded large quantities of substandard medicines and resulted in several arrests.
None | 12 Mar 2010 | Africa Fighting Malaria
Quality Chemical Industries Limited of Uganda has been found to be operating in compliance with WHO Good Manufacturing Practices. This is an impressive start for local pharmaceutical manufacturing in Africa. However, there are still some big hurdles to clear: will they get WHO prequalification or SRA approval for a particular drug, after which they would be eligible for donor funding, and will they be able to produce at a low enough price to be competitive?
Jasson Urbach & Richard Tren | 03 Feb 2010 | Health Policy Unit
A consignment of fake anti-malaria drugs worth an estimated N10 million (approximately R500,000) was seized recently by the Nigerian National Agency of Food and Drugs Administration and Control (NAFDAC). Fake drugs do not cure patients' ailments. Usually they contain little
if any active ingredient and often contain chemicals that not only fail
to treat the underlying ailment but also cause direct harm to the
None | 05 Oct 2009 | Africa Fighting Malaria
In May 2009, the March of Washingtons distributed $30,000 to Soft Power Health for the purchase and distribution of antimalarial drugs in Uganda. Click here to watch a video update from Uganda.
Roger Bate | 01 Oct 2009 | American.com
The Indian government is touting a new survey showing a low percentage of drugs within the country are counterfeit. But the reality is that India still has a major problem with poor-quality drugs.
Roger Bate | 28 Sep 2009 | Wall Street Journal
Donating money to boost African access to essential drugs is a wonderful thing. But unless philanthropists insist on market principles in the continent's drug market, and until they apply necessary due diligence when cutting checks, their aid stands to be hijacked by governmental opportunism, incompetence and corruption.